Toggle light / dark theme

Groundbreaking study shows how lifestyle changes can reverse biological aging

In a groundbreaking study led by Dr. Karen Fitzgerald, six women between the ages of 45 and 65 experienced a remarkable reduction in their biological age by an average of five years in just eight weeks. The findings offer promising insights into the potential of lifestyle changes to combat aging.

The study, which focused on the distinction between chronological age and biological age, revealed that while chronological age remains fixed, biological age — the age of one’s cells — can be influenced and even reversed through targeted interventions.

Using Dr. Steven Horvath’s epigenetic clock, which measures 353 markers associated with methylation changes linked to aging, the researchers assessed the participants’ biological age before and after the intervention.

Senolytic CAR T cells reverse aging-associated defects in intestinal regeneration and fitness

Intestinal stem cells (ISCs) drive the rapid regeneration of the gut epithelium to maintain organismal homeostasis. Aging, however, significantly reduces intestinal regenerative capacity. While cellular senescence is a key feature of the aging process, little is known about the in vivo effects of senescent cells on intestinal fitness. Here, we identify the accumulation of senescent cells in the aging gut and, by harnessing senolytic CAR T cells to eliminate them, we uncover their detrimental impact on epithelial integrity and overall intestinal homeostasis in natural aging, injury and colitis. Ablation of intestinal senescent cells with senolytic CAR T cells in vivo or in vitro is sufficient to promote the regenerative potential of aged ISCs. This intervention improves epithelial integrity and mucosal immune function. Overall, these results highlight the ability of senolytic CAR T cells to rejuvenate the intestinal niche and demonstrate the potential of targeted cell therapies to promote tissue regeneration in aging organisms.

PubMed Disclaimer

Multiomic approach boosts disease prediction accuracy beyond traditional methods

🧬🔬📊


In a recent study published in the journal Nature Aging, researchers assessed the added predictive value of integrating polygenic risk scores (PRSs) and gut microbiome scores with conventional risk factors for common diseases in a long-term cohort study.

Analysis: Integration of polygenic and gut metagenomic risk prediction for common diseases. Image Credit: remotevfx.com / Shutterstock.

Background

Multiomic technologies are transforming disease prediction by integrating genomic and microbiomic data, offering new insights into age-related conditions like heart disease, diabetes, and cancer. Previously, risk assessments relied mainly on demographic, lifestyle, and clinical metrics. Now, the integration of PRSs and gut microbiome analysis into risk models promises to improve predictive accuracy beyond traditional factors. PRSs provide a cost-effective genetic predisposition metric, while the gut microbiome adds a novel dimension to understanding disease risk. This emerging approach necessitates further research to refine its accuracy and ensure its effectiveness across various populations and healthcare systems.

Anti-Aging Breakthrough? This FDA-Approved Procedure Reversed Aging in Multiple Clocks In Human Trial

Plasma exchange human trials.


TPE Treatment, is an FDA-approved treatment for many autoimmune diseases, shows age reversal identified by multiple biological clocks. It improved both physical strength and mental health in human clinical trial(unpublished data) presented by Dr. Kiprov.

TPE Treatment remove certain harmful substances circulating in plasma to nourish cellular habitat and support regenerative factors. A special machine separates the polluted plasma from blood cells. The aged, polluted plasma is discarded and replaced with clean, individualized, plasma-like replacement fluids, albumin, immunoglobins and other regeneration promoting factors. The new solution of freshly-cleaned blood is infused back to the body.

Reference Links:
https://link.springer.com/article/10…
https://www.lifespan.io/news/plasma-d…
https://pubmed.ncbi.nlm.nih.gov/34074…
https://link.springer.com/article/10…

More About Dr. Kiprov:

Is Aging a Disease? Epigenetics with David Sinclair & Neil deGrasse Tyson

A time question and answer starting at 32:22 (5−6 years)


Is aging a disease that can be cured? Neil deGrasse Tyson and cohosts Chuck Nice and Gary O’Reilly discover the field of epigenetics, the Information Theory of Aging, and curing blindness for mice with Professor of Genetics at Harvard Medical School, David Sinclair.

What is epigenetics? Discover the difference between genetics and epigenetics. We discuss whether aging is a disease and if there have been any changes in aging throughout the centuries. David breaks down the information theory of aging and how epigenetic inheritance works. Plus, Chuck tells us about some of the studies he’s reading and how behaviors during your lifetime can be epigenetically passed onto your children.

Could we someday cure death? What does aging look like in the broader animal kingdom? We look at aging from an evolutionary standpoint, restoring vision in blind mice, and what the length of your telomeres tells you. We break down conflicting information regarding diet and how to not just live longer but live younger, longer. What are the genes that control aging?

We break down what anti-aging medicine would look like and whether it would be affordable for everyday people. Learn about the world’s oldest mice with the youngest eyes. We discuss the Yamanaka genes and how they can be utilized to turn back time on a cellular level. Is DNA destiny?

/* */